Free Trial

Margaret Kaczor Analyst Performance

Analyst at William Blair

Margaret Kaczor is a stock analyst at William Blair in the medical sector, covering 5 publicly traded companies. Over the past year, Margaret Kaczor has issued 1 stock ratings, including and hold recommendations. While full access to Margaret Kaczor's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Margaret Kaczor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 10 Years
Buy Recommendations
60.00% 3 Buy Ratings
Companies Covered
5 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy60.0%3 ratings
Hold40.0%2 ratings
Sell0.0%0 ratings

Out of 5 total stock ratings issued by Margaret Kaczor at William Blair, the majority (60.0%) have been Buy recommendations, followed by 40.0% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
60.0% of companies on NYSE
3 companies
NASDAQ
40.0% of companies on NASDAQ
2 companies

Margaret Kaczor, an analyst at William Blair, currently covers 5 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
5 companies
100.0%

Margaret Kaczor of William Blair specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
2 companies
40.0%
MED/DENTAL - SUPP
1 company
20.0%
MED PRODUCTS
1 company
20.0%
MED - OUTP/HM CRE
1 company
20.0%

Margaret Kaczor's Ratings History at William Blair

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Penumbra, Inc. stock logo
PEN
Penumbra
1/15/2026Downgrade$351.49Market Perform
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2/12/2025Downgrade$21.88Market Perform
CVRx, Inc. stock logo
CVRX
CVRx
1/14/2025Upgrade$15.04Outperform